Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Autoimmune Disorders

  Free Subscription


Articles published in Brain

Retrieve available abstracts of 52 articles:
HTML format
Text format



Single Articles


    June 2018
  1. MACHADO-SANTOS J, Saji E, Troscher AR, Paunovic M, et al
    The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells.
    Brain. 2018 Jun 4. pii: 5032773. doi: 10.1093.
    PubMed     Text format     Abstract available


  2. STANKOFF B, Louapre C
    Can we use regional grey matter atrophy sequence to stage neurodegeneration in multiple sclerosis?
    Brain. 2018;141:1580-1583.
    PubMed     Text format    


    May 2018
  3. CAMARA-LEMARROY CR, Metz L, Meddings JB, Sharkey KA, et al
    The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics.
    Brain. 2018 May 30. pii: 5025744. doi: 10.1093.
    PubMed     Text format     Abstract available


  4. BARRO C, Benkert P, Disanto G, Tsagkas C, et al
    Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis.
    Brain. 2018 May 30. pii: 5025690. doi: 10.1093.
    PubMed     Text format     Abstract available


  5. ESHAGHI A, Marinescu RV, Young AL, Firth NC, et al
    Progression of regional grey matter atrophy in multiple sclerosis.
    Brain. 2018 May 8. pii: 4993898. doi: 10.1093.
    PubMed     Text format     Abstract available


  6. LADISLAU L, Suarez-Calvet X, Toquet S, Landon-Cardinal O, et al
    JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis.
    Brain. 2018 May 8. pii: 4993951. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2018
  7. CONRAD BN, Barry RL, Rogers BP, Maki S, et al
    Multiple sclerosis lesions affect intrinsic functional connectivity of the spinal cord.
    Brain. 2018 Apr 10. pii: 4965865. doi: 10.1093.
    PubMed     Text format     Abstract available


  8. VAN LANGELAAR J, van der Vuurst de Vries RM, Janssen M, Wierenga-Wolf AF, et al
    T helper 17.1 cells associate with multiple sclerosis disease activity: perspectives for early intervention.
    Brain. 2018 Apr 5. pii: 4961484. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2018
  9. STEYERBERG EW, Claggett B
    Towards personalized therapy for multiple sclerosis: limitations of observational data.
    Brain. 2018 Mar 3. pii: 4919652. doi: 10.1093.
    PubMed     Text format    


  10. KALINCIK T
    Reply: Towards personalized therapy for multiple sclerosis: limitations of observational data.
    Brain. 2018 Mar 3. pii: 4919653. doi: 10.1093.
    PubMed     Text format    


  11. STEPHENSON EL, Mishra MK, Moussienko D, Laflamme N, et al
    Chondroitin sulfate proteoglycans as novel drivers of leucocyte infiltration in multiple sclerosis.
    Brain. 2018 Mar 1. pii: 4915907. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2018
  12. ARRAMBIDE G, Tintore M, Espejo C, Auger C, et al
    The value of oligoclonal bands in the multiple sclerosis diagnostic criteria.
    Brain. 2018 Feb 16. pii: 4866204. doi: 10.1093.
    PubMed     Text format     Abstract available


    January 2018
  13. SMETS I, Fiddes B, Garcia-Perez JE, He D, et al
    Multiple sclerosis risk variants alter expression of co-stimulatory genes in B cells.
    Brain. 2018 Jan 18. pii: 4817414. doi: 10.1093.
    PubMed     Text format     Abstract available


    December 2017
  14. KIM RY, Mangu D, Hoffman AS, Kovash R, et al
    Oestrogen receptor beta ligand acts on CD11c+ cells to mediate protection in experimental autoimmune encephalomyelitis.
    Brain. 2017 Dec 8. pii: 4710057. doi: 10.1093.
    PubMed     Text format     Abstract available


    October 2017
  15. GRANBERG T, Fan Q, Treaba CA, Ouellette R, et al
    In vivo characterization of cortical and white matter neuroaxonal pathology in early multiple sclerosis.
    Brain. 2017 Oct 10. doi: 10.1093.
    PubMed     Text format     Abstract available


    September 2017
  16. ROCCA MA, Sormani MP, Rovaris M, Caputo D, et al
    Long-term disability progression in primary progressive multiple sclerosis: a 15-year study.
    Brain. 2017 Sep 27. doi: 10.1093.
    PubMed     Text format     Abstract available


  17. DATTA G, Colasanti A, Rabiner EA, Gunn RN, et al
    Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis.
    Brain. 2017 Sep 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  18. KALINCIK T, Manouchehrinia A, Sobisek L, Jokubaitis V, et al
    Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.
    Brain. 2017;140:2426-2443.
    PubMed     Text format     Abstract available


    July 2017
  19. SCOLDING NJ, Pasquini M, Reingold SC, Cohen JA, et al
    Cell-based therapeutic strategies for multiple sclerosis.
    Brain. 2017 Jul 21. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2017
  20. DELMONT E, Manso C, Querol L, Cortese A, et al
    Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy.
    Brain. 2017 May 28. doi: 10.1093.
    PubMed     Text format     Abstract available


  21. ZRZAVY T, Hametner S, Wimmer I, Butovsky O, et al
    Loss of 'homeostatic' microglia and patterns of their activation in active multiple sclerosis.
    Brain. 2017 May 24. doi: 10.1093.
    PubMed     Text format     Abstract available


  22. HACOHEN Y, Ciccarelli O, Hemingway C
    Abnormal white matter development in children with multiple sclerosis and monophasic acquired demyelination.
    Brain. 2017;140:1172-1174.
    PubMed     Text format    


    April 2017
  23. EL BEHI M, Sanson C, Bachelin C, Guillot-Noel L, et al
    Adaptive human immunity drives remyelination in a mouse model of demyelination.
    Brain. 2017;140:967-980.
    PubMed     Text format     Abstract available


    March 2017
  24. LONGONI G, Brown RA, MomayyezSiahkal P, Elliott C, et al
    White matter changes in paediatric multiple sclerosis and monophasic demyelinating disorders.
    Brain. 2017 Mar 14. doi: 10.1093.
    PubMed     Text format     Abstract available


  25. JURYNCZYK M, Geraldes R, Probert F, Woodhall MR, et al
    Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis.
    Brain. 2017;140:617-627.
    PubMed     Text format     Abstract available


    February 2017
  26. PONATH G, Ramanan S, Mubarak M, Housley W, et al
    Myelin phagocytosis by astrocytes after myelin damage promotes lesion pathology.
    Brain. 2017;140.
    PubMed     Text format     Abstract available


    January 2017
  27. BROWN JW, Pardini M, Brownlee WJ, Fernando K, et al
    An abnormal periventricular magnetization transfer ratio gradient occurs early in multiple sclerosis.
    Brain. 2017 Jan 2. pii: aww296. doi: 10.1093.
    PubMed     Text format     Abstract available


    October 2016
  28. CORREALE J, Gaitan MI, Ysrraelit MC, Fiol MP, et al
    Progressive multiple sclerosis: from pathogenic mechanisms to treatment.
    Brain. 2016.
    PubMed     Text format     Abstract available


  29. ZEKERIDOU A, Lennon VA
    Memory in autoimmune NMDA receptor encephalitis: an issue for B cells and patients.
    Brain. 2016;139.
    PubMed     Text format    


    August 2016
  30. KNIER B, Schmidt P, Aly L, Buck D, et al
    Retinal inner nuclear layer volume reflects response to immunotherapy in multiple sclerosis.
    Brain. 2016.
    PubMed     Text format     Abstract available


  31. KREYE J, Wenke NK, Chayka M, Leubner J, et al
    Human cerebrospinal fluid monoclonal N-methyl-D-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesis.
    Brain. 2016.
    PubMed     Text format     Abstract available


    July 2016
  32. MACREZ R, Ortega MC, Bardou I, Mehra A, et al
    Neuroendothelial NMDA receptors as therapeutic targets in experimental autoimmune encephalomyelitis.
    Brain. 2016.
    PubMed     Text format     Abstract available


  33. LORSCHEIDER J, Buzzard K, Jokubaitis V, Spelman T, et al
    Defining secondary progressive multiple sclerosis.
    Brain. 2016.
    PubMed     Text format     Abstract available


    June 2016
  34. ARAUJO AQ, Silva MT, Araujo AP
    Zika virus-associated neurological disorders: a review.
    Brain. 2016.
    PubMed     Text format     Abstract available


  35. VAN DOORN PA, Jacobs BC
    Neuronal endocytosis of anti-ganglioside antibodies: implications for Guillain-Barre syndrome.
    Brain. 2016;139.
    PubMed     Text format    


    May 2016
  36. LAHORIA R, Selcen D, Engel AG
    Microvascular alterations and the role of complement in dermatomyositis.
    Brain. 2016.
    PubMed     Text format     Abstract available


    April 2016
  37. SEVERIN ME, Lee PW, Liu Y, Selhorst AJ, et al
    MicroRNAs targeting TGFbeta signalling underlie the regulatory T cell defect in multiple sclerosis.
    Brain. 2016.
    PubMed     Text format     Abstract available


  38. ALLENBACH Y, Keraen J, Bouvier AM, Jooste V, et al
    High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody.
    Brain. 2016.
    PubMed     Text format     Abstract available


    March 2016
  39. RAMADAN A, Lucca LE, Carrie N, Desbois S, et al
    In situ expansion of T cells that recognize distinct self-antigens sustains autoimmunity in the CNS.
    Brain. 2016.
    PubMed     Text format     Abstract available


  40. ERCAN E, Magro-Checa C, Valabregue R, Branzoli F, et al
    Glial and axonal changes in systemic lupus erythematosus measured with diffusion of intracellular metabolites.
    Brain. 2016.
    PubMed     Text format     Abstract available


  41. KILSDONK ID, Jonkman LE, Klaver R, van Veluw SJ, et al
    Increased cortical grey matter lesion detection in multiple sclerosis with 7 T MRI: a post-mortem verification study.
    Brain. 2016.
    PubMed     Text format     Abstract available


  42. HAIDER L, Zrzavy T, Hametner S, Hoftberger R, et al
    The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain.
    Brain. 2016;139.
    PubMed     Text format     Abstract available


    February 2016
  43. IRANI SR
    'Moonlighting' surface antigens: a paradigm for autoantibody pathogenicity in neurology?
    Brain. 2016;139.
    PubMed     Text format    


    January 2016
  44. PETRACCA M, Vancea RO, Fleysher L, Jonkman LE, et al
    Brain intra- and extracellular sodium concentration in multiple sclerosis: a 7 T MRI study.
    Brain. 2016.
    PubMed     Text format     Abstract available


  45. CHARD DT, Miller DH
    What lies beneath grey matter atrophy in multiple sclerosis?
    Brain. 2016;139.
    PubMed     Text format    


  46. FRIESE MA
    Widespread synaptic loss in multiple sclerosis.
    Brain. 2016;139.
    PubMed     Text format    


    December 2015
  47. JURGENS T, Jafari M, Kreutzfeldt M, Bahn E, et al
    Reconstruction of single cortical projection neurons reveals primary spine loss in multiple sclerosis.
    Brain. 2015.
    PubMed     Text format     Abstract available


  48. STEENWIJK MD, Geurts JJ, Daams M, Tijms BM, et al
    Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant.
    Brain. 2015.
    PubMed     Text format     Abstract available


    November 2015
  49. WERNER C, Pauli M, Doose S, Weishaupt A, et al
    Human autoantibodies to amphiphysin induce defective presynaptic vesicle dynamics and composition.
    Brain. 2015.
    PubMed     Text format     Abstract available


  50. KULLMANN DM
    Brain. Editorial.
    Brain. 2015;138.
    PubMed     Text format    


  51. MUSOLINO PL, Gong Y, Snyder JM, Jimenez S, et al
    Brain endothelial dysfunction in cerebral adrenoleukodystrophy.
    Brain. 2015;138.
    PubMed     Text format     Abstract available


    September 2015
  52. WRIGHT S, Hashemi K, Stasiak L, Bartram J, et al
    Epileptogenic effects of NMDAR antibodies in a passive transfer mouse model.
    Brain. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: